Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Wick

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Oncology Reports|October 18, 2000
L-dopa-resistant parkinsonism syndrome following cerebral radiation therapy for neoplasmW Wick, F Hochberg, J O'Sullivan, et al.
Journal of Neurology|June 11, 2003
A prospective trial of mechanical physiotherapy for lumbar disk prolapseD Brötz, W Küker, E Maschke, et al.
Clinical Neuroradiology|June 18, 2011
Neuroradiological response criteria for high-grade gliomasK Lutz, A Radbruch, B Wiestler, et al.
Biochemical and Biophysical Research Communications|February 19, 2000
Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expressionM Platten, W Wick, C Wild-Bode, et al.
International Journal of Cancer|June 8, 2001
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cellsM Platten, C Wild-Bode, W Wick, et al.
FEBS Letters|January 1, 1999
BCL-2 promotes migration and invasiveness of human glioma cellsW Wick, S Wagner, S Kerkau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2W Wick, C Grimmel, C Wild-Bode, et al.
Neurology|August 19, 2007
Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemiaM Platten, C A Opitz, P Kohlhof, et al.
Neurology|June 9, 2004
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastomaW Wick, J P Steinbach, W M Küker, et al.
Journal of Neuro-Oncology|September 4, 2009
Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcomeA Wick, N Schäfer, N Dörner, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Oncology Reports|October 18, 2000
L-dopa-resistant parkinsonism syndrome following cerebral radiation therapy for neoplasmW Wick, F Hochberg, J O'Sullivan, et al.
Journal of Neurology|June 11, 2003
A prospective trial of mechanical physiotherapy for lumbar disk prolapseD Brötz, W Küker, E Maschke, et al.
Clinical Neuroradiology|June 18, 2011
Neuroradiological response criteria for high-grade gliomasK Lutz, A Radbruch, B Wiestler, et al.
Biochemical and Biophysical Research Communications|February 19, 2000
Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expressionM Platten, W Wick, C Wild-Bode, et al.
International Journal of Cancer|June 8, 2001
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cellsM Platten, C Wild-Bode, W Wick, et al.
FEBS Letters|January 1, 1999
BCL-2 promotes migration and invasiveness of human glioma cellsW Wick, S Wagner, S Kerkau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2W Wick, C Grimmel, C Wild-Bode, et al.
Neurology|August 19, 2007
Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemiaM Platten, C A Opitz, P Kohlhof, et al.
Neurology|June 9, 2004
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastomaW Wick, J P Steinbach, W M Küker, et al.
Journal of Neuro-Oncology|September 4, 2009
Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcomeA Wick, N Schäfer, N Dörner, et al.
Pageof 8